Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like Meet the Scientist Who Admits His MS Therapy is 'Largely Ineffective.' November 28, 2017 Top 10 R&D Scientist Skills in Demand April 26, 2017 Theranos, Reach Agreement On Full Restitution To State Consumers April 17, 2017